Oskar Angerås

TL;DR: Routine thrombus aspiration before PCI as compared with PCI alone did not reduce 30-day mortality among patients with STEMI, and results were consistent across all major prespecified subgroups, including subgroups defined according toThrombus burden and coronary flow before PCI.

TL;DR: In patients with STEMI and multivessel disease who underwent primary PCI of an infarct‐related artery, the addition of FFR‐guided complete revascularization of non‐infarCT‐related coronary arteries in the acute setting resulted in a risk of a composite cardiovascular outcome that was lower than the risk among those who were treated for the infarction only.

TL;DR: The proportion of acute coronary syndromes attributed to takotsubo syndrome in Western Sweden has increased over the last decade, with similar early and late mortality as STEMI and NSTEMI.

TL;DR: In patients with significant CAD undergoing coronary artery by-pass grafting and in patients with no significant CAD, there was no difference in mortality risk in the overweight groups compared with the normal weight group, strengthening the concept of the obesity paradox substantially.

TL;DR: The rate of the composite of death from any cause, myocardial infarction, or major bleeding was not lower among those who received bivalirudin than among thosewho received heparin monotherapy, and the results were consistent between patients with STEMI and those with NSTEMI and across other major subgroups.